Translation Error

The coronary artery disease segment is expected to cross USD 2.9 billion by 2034.

The market size of wearable cardiac devices was valued at USD 2.4 billion in 2024 and is expected to reach around USD 7.5 billion by 2034, growing at 12% CAGR through 2034.

The U.S. market of wearable cardiac devices is likely to reach USD 2.7 billion by 2034.

Some of the major players in the industry include Abbot Laboratories, Boston Scientific, Cardiac Insight, CardiacSense, Cardiac Rhythm, iRhythm Technologies, Integra LifeSciences, Koninklijke Philips, Medtronic, Proteus Digital Health, Qardio, ZOLL Medical Corporation.